بروهارت 12
ProHeart 12 (moxidectin) is an extended-release injectable microsphere suspension that provides 12 full months of continuous protection against heartworm disease caused by Dirofilaria immitis and treats existing hookworm infections in dogs 12 months of age and older.
Dosage Form
Suspension
Product Type
Pharmaceutical
Manufacturer
Package
Pack containing 1 vial of moxidectin sterile microspheres (solid) and 1 vial of sterile reconstitution vehicle (yields 10 mg/mL)
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Dog | 0.5 mg moxidectin/kg body weight (0.05 mL reconstituted suspension per kg) | Subcutaneous (SC) | Once every 12 months |
No withdrawal information available.
Prevention of heartworm disease caused by Dirofilaria immitis for 12 months in dogs 12 months of age and older.
Treatment of existing larval and adult hookworm infections (Ancylostoma caninum and Uncinaria stenocephala) at the time of administration.
Do not administer to sick, debilitated, underweight, or heartworm-positive dogs.
Do not use in dogs under 12 months of age.
Do not administer intravenously or intramuscularly.
Prior to administration, dogs should be tested for existing heartworm infections.
Veterinarians must complete certification training prior to prescribing and administering ProHeart 12.
Caution in dogs with history of allergic reactions, vaccine reactions, or immune-mediated diseases.
Anaphylaxis/hypersensitivity reactions (facial swelling, pruritus, urticaria), vomiting, diarrhea, lethargy, and localized swelling or granuloma at the injection site.
ProHeart 12 Prescribing Information
Leaflet10 mg/mL
No diseases linked.
No data available
Information has not been added yet.
Manufacturer
No alternatives available.